Sequencing of chronic myeloid leukemia (CML) cell lines upon upregulation or downregulation of G0/G1 switch gene (G0S2)

ABSTRACT: Current treatment for CML involves tyrosine kinase inhibitors (TKIs), which turned it into a managable disease. In a transcriptional profile of TKI-resistant versus newly diagnosed CML patient samples, G0S2 was shown to be profoundly downregulated.

ORGANISM(S): Homo sapiens

PROVIDER: GSE171945 | GEO | 2021/04/13

REPOSITORIES: GEO